Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical OLT1177 Gel for Knee Osteoarthritis Pain
NCT01768975Phase 2Completed
- Sponsor
- Olatec Therapeutics LLC
- Start
- Jan 2013
- Primary completion
- Aug 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in knee osteoarthritis (OA) comparing OLT1177 Gel with Placebo Gel (2 arms). Primary endpoint: Change in WOMAC knee pain subscale at 14 days. Started Jan 2013; status: completed.
02
Drugs
dapansutrile
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT01768975.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01768975.